Single-Agent Irinotecan for Recurrent/Metastatic Colorectal Cancer: A Retrospective Analysis

Publisher： Karger

E-ISSN： 1423-0151|15|4|288-292

ISSN： 1011-7571

Source： Medical Principles and Practice, Vol.15, Iss.4, 2006-06, pp. : 288-292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

WITHDRAWN: Irinotecan plus Weekly 5-Fluorouracil and Leucovorin as Salvage Treatment for Patients with Metastatic Colorectal Cancer: A Phase II Trial

By  

Digestive Diseases, Vol. 25, Iss. 1, 2007-03 ,pp. : 100-105

Karger

Access to resources Recommend Favorite

Retrospective Study as First-Line Chemotherapy Combined Anti-VEGF Antibody with Fluoropyrimidine for Frail Patients with Unresectable or Metastatic Colorectal Cancer

By  

Digestion, Vol. 87, Iss. 1, 2013-01 ,pp. : 59-64

Karger

Access to resources Recommend Favorite

Irinotecan Plus Gemcitabine and Fluorouracil in Advanced Biliary Tract Cancer: A Retrospective Study

By  

Digestion, Vol. 93, Iss. 3, 2016-04 ,pp. : 229-233

Karger

Access to resources Recommend Favorite

Advances in Chemotherapy against Advanced or Metastatic Colorectal Cancer

By  

Digestion, Vol. 77, Iss. 1, 2008-01 ,pp. : 13-22

Karger

Access to resources Recommend Favorite

Multivisceral Resection for T4 or Recurrent Colorectal Cancer

By  

Digestive Diseases, Vol. 30, Iss. 2, 2012-11 ,pp. : 96-101

Karger

Access to resources Recommend Favorite